BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24746576)

  • 1. Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity.
    Fachal L; Mosquera-Miguel A; Gómez-Caamaño A; Sánchez-García M; Calvo P; Lobato-Busto R; Salas A; Vega A
    Radiother Oncol; 2014 May; 111(2):199-205. PubMed ID: 24746576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort.
    Fachal L; Gómez-Caamaño A; Alvarez Iglesias V; Gómez Carballa A; Calvo P; Salas A; Vega A
    J Hum Genet; 2014 Jul; 59(7):411-4. PubMed ID: 24898828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
    Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
    Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
    Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
    Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence that major mtDNA European haplogroups confer risk to schizophrenia.
    Mosquera-Miguel A; Torrell H; Abasolo N; Arrojo M; Paz E; Ramos-Ríos R; Agra S; Páramo M; Brenlla J; Martínez S; Vilella E; Valero J; Gutiérrez-Zotes A; Martorell L; Costas J; Salas A
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jun; 159B(4):414-21. PubMed ID: 22467472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
    Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
    Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population.
    Fachal L; Mosquera-Miguel A; Pastor P; Ortega-Cubero S; Lorenzo E; Oterino-Durán A; Toriello M; Quintáns B; Camiña-Tato M; Sesar A; Vega A; Sobrido MJ; Salas A
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):54-65. PubMed ID: 25349034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
    Andreassen CN; Rosenstein BS; Kerns SL; Ostrer H; De Ruysscher D; Cesaretti JA; Barnett GC; Dunning AM; Dorling L; West CML; Burnet NG; Elliott R; Coles C; Hall E; Fachal L; Vega A; Gómez-Caamaño A; Talbot CJ; Symonds RP; De Ruyck K; Thierens H; Ost P; Chang-Claude J; Seibold P; Popanda O; Overgaard M; Dearnaley D; Sydes MR; Azria D; Koch CA; Parliament M; Blackshaw M; Sia M; Fuentes-Raspall MJ; Ramon Y Cajal T; Barnadas A; Vesprini D; Gutiérrez-Enríquez S; Mollà M; Díez O; Yarnold JR; Overgaard J; Bentzen SM; Alsner J;
    Radiother Oncol; 2016 Dec; 121(3):431-439. PubMed ID: 27443449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.
    Fachal L; Gómez-Caamaño A; Barnett GC; Peleteiro P; Carballo AM; Calvo-Crespo P; Kerns SL; Sánchez-García M; Lobato-Busto R; Dorling L; Elliott RM; Dearnaley DP; Sydes MR; Hall E; Burnet NG; Carracedo Á; Rosenstein BS; West CM; Dunning AM; Vega A
    Nat Genet; 2014 Aug; 46(8):891-4. PubMed ID: 24974847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.
    Ahmed M; Dorling L; Kerns S; Fachal L; Elliott R; Partliament M; Rosenstein BS; Vega A; Gómez-Caamaño A; Barnett G; Dearnaley DP; Hall E; Sydes M; Burnet N; Pharoah PD; Eeles R; West CM
    Br J Cancer; 2016 May; 114(10):1165-74. PubMed ID: 27070714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer.
    Damaraju S; Murray D; Dufour J; Carandang D; Myrehaug S; Fallone G; Field C; Greiner R; Hanson J; Cass CE; Parliament M
    Clin Cancer Res; 2006 Apr; 12(8):2545-54. PubMed ID: 16638864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common European Mitochondrial Haplogroups in the Risk for Radiation-induced Subcutaneous Fibrosis in Breast Cancer Patients.
    Terrazzino S; Deantonio L; Cargnin S; Donis L; Pisani C; Masini L; Gambaro G; Canonico PL; Genazzani AA; Krengli M
    Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):365-72. PubMed ID: 26970669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.
    Langsenlehner T; Renner W; Gerger A; Hofmann G; Thurner EM; Kapp KS; Langsenlehner U
    Strahlenther Onkol; 2011 Dec; 187(12):784-91. PubMed ID: 22105769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients.
    Fachal L; Gómez-Caamaño A; Peleteiro P; Carballo A; Calvo-Crespo P; Sánchez-García M; Lobato-Busto R; Carracedo A; Vega A
    Radiother Oncol; 2012 Dec; 105(3):321-8. PubMed ID: 23075580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
    Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
    J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients.
    Fachal L; Gómez-Caamaño A; Sánchez-García M; Carballo A; Peleteiro P; Lobato-Busto R; Carracedo A; Vega A
    Radiother Oncol; 2012 May; 103(2):206-9. PubMed ID: 22385796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
    Schack LMH; Petersen SE; Nielsen S; Lundby L; Høyer M; Bentzen L; Overgaard J; Andreassen CN; Alsner J
    Acta Oncol; 2017 Nov; 56(11):1514-1521. PubMed ID: 28844157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.
    Dolezel M; Odrazka K; Vaculikova M; Vanasek J; Sefrova J; Paluska P; Zouhar M; Jansa J; Macingova Z; Jarosova L; Brodak M; Moravek P; Hartmann I
    Strahlenther Onkol; 2010 Apr; 186(4):197-202. PubMed ID: 20354663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.